pH-Responsive Ionizable Lipids for Nucleic Acid Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current lipid-based nanoparticles for nucleic acid delivery induce dose-limiting toxicities such as complement activation-related pseudo-allergy and inflammatory cytokine release, necessitating improved ionizable lipid chemistries for enhanced efficacy and safety.
Innovation Solution
Development of a new class of ionizable lipids represented by specific formulas with varied alkyl, alkenyl, and alkynyl groups, heterocycles, and linkers to enhance stability, cellular uptake, and endosomal escape, while minimizing toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional ionizable lipids are used in lipid-based nanoparticles for nucleic acid delivery, then efficient encapsulation and cellular uptake are achieved, but dose-limiting toxicities such as complement activation-related pseudo-allergy and inflammatory cytokine release occur
Solution Approach 1:
The patent applies parameter changes by systematically modifying the chemical structure of ionizable lipids through variations in the R1-R7 substituents, alkyl chain lengths, and heterocyclic groups. These structural parameter changes enable optimization of both delivery efficacy and safety profile by adjusting properties such as pKa, membrane affinity, and immunogenicity without fundamentally changing the lipid architecture
Solution Approach 2:
The invention employs composite materials by designing ionizable lipids that combine multiple functional moieties within a single molecular structure - including heterocyclic rings, adjustable alkyl chains, and specific substituent patterns. This composite approach allows simultaneous achievement of stable nanoparticle formation, efficient cellular uptake, and reduced toxicity through synergistic structural features
2Productivity
If ionizable lipids are accumulated in cellular membranes to achieve effective nucleic acid delivery, then cellular uptake and endosomal escape are enhanced, but cellular toxicities increase due to non-degradable lipid accumulation
Solution Approach 1:
The patent applies dynamics by designing ionizable lipids with pH-responsive properties that enable dynamic behavior - the lipids become more membrane-active at acidic endosomal pH for efficient escape, but exhibit reduced activity at physiological pH to minimize accumulation-related toxicity. The dynamic pKa adjustment based on environmental conditions allows the lipid to perform different functions at different stages of the delivery process
Solution Approach 2:
The invention uses local quality by creating lipids with spatially differentiated functional regions - the heterocyclic head group provides localized interaction with nucleic acids and endosomal membranes, while the adjustable alkyl chains (R1-R7) provide localized control over membrane fluidity and stability. This local functional differentiation enables efficient delivery at the target site while minimizing off-target toxicity
Data Source
AI summary
The present invention generally relates to the field of ionizable (also termed cationic) lipids, and in particular provides a novel type of such lipids as represented by any of the formulae disclosed herein. The present invention further provides methods for making such lipids as well as uses thereof, in particular in the preparation of nanoparticle compositions, more in particular nanoparticle compositions comprising nucleic acids. It further provides vaccine formulations and pharmaceutical formulations comprising nanoparticle compositions based on the ionizable lipids disclosed herein.